Geneos Wealth Management’s Arch Capital ACGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3K Hold
127
﹤0.01% 1949
2026
Q1
$12.2K Sell
127
-4
-3% -$383 ﹤0.01% 1932
2025
Q4
$12.6K Buy
131
+18
+16% +$1.65K ﹤0.01% 1891
2025
Q3
$10.3K Sell
113
-570
-83% -$51.1K ﹤0.01% 1952
2025
Q2
$62.2K Buy
683
+10
+1% +$923 ﹤0.01% 1455
2025
Q1
$64.7K Buy
673
+412
+158% +$38K ﹤0.01% 1347
2024
Q4
$24.1K Hold
261
﹤0.01% 1634
2024
Q3
$29.2K Buy
+261
New +$27.1K ﹤0.01% 1406
2023
Q4
Sell
-40
Closed -$3.19K 2092
2023
Q3
$3.19K Hold
40
﹤0.01% 1853
2023
Q2
$2.99K Hold
40
﹤0.01% 1859
2023
Q1
$2.71K Hold
40
﹤0.01% 1854
2022
Q4
$2.51K Hold
40
﹤0.01% 1847
2022
Q3
$1K Hold
40
﹤0.01% 1897
2022
Q2
$1K Buy
40
+1
+3% +$46 ﹤0.01% 2455
2022
Q1
$1K Buy
+39
New +$1.81K ﹤0.01% 2604

Other funds holding ACGL

Geneos Wealth Management's ACGL Position: Q2 2026 in Review

Geneos Wealth Management held its Arch Capital (ACGL) position steady in Q2 2026 at 127 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1949.

Geneos Wealth Management first reported a position in ACGL in Q1 2022 and has held it in 15 quarters since. The position peaked at $64.7K in Q1 2025. 906 funds tracked by Wall St. Rank hold ACGL as of Q2 2026.

  • Geneos Wealth Management held 127 shares of Arch Capital worth $12.3K as of Q2 2026.
  • Geneos Wealth Management left its Arch Capital share count unchanged in Q2 2026.
  • Arch Capital made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1949 holding.
  • Geneos Wealth Management first reported a position in Arch Capital in Q1 2022 and has held it in 15 quarters since.
  • Geneos Wealth Management's Arch Capital position peaked at $64.7K in Q1 2025.
  • 906 funds tracked by Wall St. Rank held Arch Capital as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.